Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patients

Detalhes bibliográficos
Autor(a) principal: Sant'Ana,Priscilla de Laet
Data de Publicação: 2002
Outros Autores: Milan,Eveline Pípolo, Martinez,Roberto, Queiroz-Telles,Flávio, Ferreira,Marcelo Simão, Alcântara,Ana Paula, Carvalho,Miriam T, Colombo,Arnaldo Lopes
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Memórias do Instituto Oswaldo Cruz
Texto Completo: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762002000200019
Resumo: Oropharyngeal candidiasis continues to be considered the most common opportunistic disease in Aids patients. This study was designed to investigate species distribution, serotype and antifungal susceptibility profile among Candida spp. isolated from the oral cavity of Aids patients recruited from six Brazilian university centers. Oral swabs from 130 Aids patients were plated onto CHROMagar Candida medium and 142 isolates were recovered. Yeast isolates were identified by classical methods and serotyped using the Candida Check® system-Iatron. Antifungal susceptibility testing was performed according to the NCCLS microbroth assay. C. albicans was the most frequently isolated species (91%), and 70% of the isolates belonged to serotype A. We detected 12 episodes of co-infection (9%), including co-infection with both serotypes of C. albicans. Non-albicans species were isolated from 12 episodes, 50% of them exhibited DDS or resistance to azoles. Otherwise, only 8 out 130 isolates of C. albicans exhibited DDS or resistance to azoles. Brazilian Aids patients are infected mainly by C. albicans serotype A, most of them susceptible to all antifungal drugs.
id FIOCRUZ-4_6af3f31d1268b538da01b9a8a0263246
oai_identifier_str oai:scielo:S0074-02762002000200019
network_acronym_str FIOCRUZ-4
network_name_str Memórias do Instituto Oswaldo Cruz
spelling Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patientsoral candidiasisCandida spp.AidsBrazilOropharyngeal candidiasis continues to be considered the most common opportunistic disease in Aids patients. This study was designed to investigate species distribution, serotype and antifungal susceptibility profile among Candida spp. isolated from the oral cavity of Aids patients recruited from six Brazilian university centers. Oral swabs from 130 Aids patients were plated onto CHROMagar Candida medium and 142 isolates were recovered. Yeast isolates were identified by classical methods and serotyped using the Candida Check® system-Iatron. Antifungal susceptibility testing was performed according to the NCCLS microbroth assay. C. albicans was the most frequently isolated species (91%), and 70% of the isolates belonged to serotype A. We detected 12 episodes of co-infection (9%), including co-infection with both serotypes of C. albicans. Non-albicans species were isolated from 12 episodes, 50% of them exhibited DDS or resistance to azoles. Otherwise, only 8 out 130 isolates of C. albicans exhibited DDS or resistance to azoles. Brazilian Aids patients are infected mainly by C. albicans serotype A, most of them susceptible to all antifungal drugs.Instituto Oswaldo Cruz, Ministério da Saúde2002-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762002000200019Memórias do Instituto Oswaldo Cruz v.97 n.2 2002reponame:Memórias do Instituto Oswaldo Cruzinstname:Fundação Oswaldo Cruzinstacron:FIOCRUZ10.1590/S0074-02762002000200019info:eu-repo/semantics/openAccessSant'Ana,Priscilla de LaetMilan,Eveline PípoloMartinez,RobertoQueiroz-Telles,FlávioFerreira,Marcelo SimãoAlcântara,Ana PaulaCarvalho,Miriam TColombo,Arnaldo Lopeseng2020-04-25T17:48:44Zhttp://www.scielo.br/oai/scielo-oai.php0074-02761678-8060opendoar:null2020-04-26 02:10:58.4Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruztrue
dc.title.none.fl_str_mv Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patients
title Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patients
spellingShingle Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patients
Sant'Ana,Priscilla de Laet
oral candidiasis
Candida spp.
Aids
Brazil
title_short Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patients
title_full Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patients
title_fullStr Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patients
title_full_unstemmed Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patients
title_sort Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patients
author Sant'Ana,Priscilla de Laet
author_facet Sant'Ana,Priscilla de Laet
Milan,Eveline Pípolo
Martinez,Roberto
Queiroz-Telles,Flávio
Ferreira,Marcelo Simão
Alcântara,Ana Paula
Carvalho,Miriam T
Colombo,Arnaldo Lopes
author_role author
author2 Milan,Eveline Pípolo
Martinez,Roberto
Queiroz-Telles,Flávio
Ferreira,Marcelo Simão
Alcântara,Ana Paula
Carvalho,Miriam T
Colombo,Arnaldo Lopes
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sant'Ana,Priscilla de Laet
Milan,Eveline Pípolo
Martinez,Roberto
Queiroz-Telles,Flávio
Ferreira,Marcelo Simão
Alcântara,Ana Paula
Carvalho,Miriam T
Colombo,Arnaldo Lopes
dc.subject.por.fl_str_mv oral candidiasis
Candida spp.
Aids
Brazil
topic oral candidiasis
Candida spp.
Aids
Brazil
dc.description.none.fl_txt_mv Oropharyngeal candidiasis continues to be considered the most common opportunistic disease in Aids patients. This study was designed to investigate species distribution, serotype and antifungal susceptibility profile among Candida spp. isolated from the oral cavity of Aids patients recruited from six Brazilian university centers. Oral swabs from 130 Aids patients were plated onto CHROMagar Candida medium and 142 isolates were recovered. Yeast isolates were identified by classical methods and serotyped using the Candida Check® system-Iatron. Antifungal susceptibility testing was performed according to the NCCLS microbroth assay. C. albicans was the most frequently isolated species (91%), and 70% of the isolates belonged to serotype A. We detected 12 episodes of co-infection (9%), including co-infection with both serotypes of C. albicans. Non-albicans species were isolated from 12 episodes, 50% of them exhibited DDS or resistance to azoles. Otherwise, only 8 out 130 isolates of C. albicans exhibited DDS or resistance to azoles. Brazilian Aids patients are infected mainly by C. albicans serotype A, most of them susceptible to all antifungal drugs.
description Oropharyngeal candidiasis continues to be considered the most common opportunistic disease in Aids patients. This study was designed to investigate species distribution, serotype and antifungal susceptibility profile among Candida spp. isolated from the oral cavity of Aids patients recruited from six Brazilian university centers. Oral swabs from 130 Aids patients were plated onto CHROMagar Candida medium and 142 isolates were recovered. Yeast isolates were identified by classical methods and serotyped using the Candida Check® system-Iatron. Antifungal susceptibility testing was performed according to the NCCLS microbroth assay. C. albicans was the most frequently isolated species (91%), and 70% of the isolates belonged to serotype A. We detected 12 episodes of co-infection (9%), including co-infection with both serotypes of C. albicans. Non-albicans species were isolated from 12 episodes, 50% of them exhibited DDS or resistance to azoles. Otherwise, only 8 out 130 isolates of C. albicans exhibited DDS or resistance to azoles. Brazilian Aids patients are infected mainly by C. albicans serotype A, most of them susceptible to all antifungal drugs.
publishDate 2002
dc.date.none.fl_str_mv 2002-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762002000200019
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762002000200019
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0074-02762002000200019
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
dc.source.none.fl_str_mv Memórias do Instituto Oswaldo Cruz v.97 n.2 2002
reponame:Memórias do Instituto Oswaldo Cruz
instname:Fundação Oswaldo Cruz
instacron:FIOCRUZ
reponame_str Memórias do Instituto Oswaldo Cruz
collection Memórias do Instituto Oswaldo Cruz
instname_str Fundação Oswaldo Cruz
instacron_str FIOCRUZ
institution FIOCRUZ
repository.name.fl_str_mv Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruz
repository.mail.fl_str_mv
_version_ 1669937685216624640